Headlines
Novo Nordisk buys Akero Therapeutics in the US
Novo Nordisk buys Akero Therapeutics in the US
Published by Global Banking and Finance Review
Posted on October 9, 2025
Published by Global Banking and Finance Review
Posted on October 9, 2025
STOCKHOLM (Reuters) -Danish drugmaker Novo Nordisk said on Thursday it had agreed to buy United States based Akero Therapeutics, a clinical-stage company developing innovative treatments for patients with serious metabolic diseases marked by a high unmet medical need.
(Reporting by Anna Ringstrom, editing by Essi Lehto)
Explore more articles in the Headlines category



